Introducing: Delft Ultra
To help find the missing people with TB, Delft introduces The Delft Ultra, an ultra-portable digital X-ray solution. The Delft Ultra includes the following key features: Wireless and compact design to enable a truly [...]
Guido Geerts Interview
Our CEO Guido Geerts discusses the history of Delft Imaging, our current work, and future projects. The conversation goes into what it means to be impact-focused and how the Delft team operates as a network [...]
Strengthening COVID-19 screening capacity in Indonesia
Delft Imaging has formalized a development partnership with the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH for COVID-19 response in Indonesia. Together with our partners Thirona, Fullerton Health Indonesia, IDBH Senso, and Faculty of [...]
Certified B Corporation
Delft Imaging is now officially B-Corp Certified! B Corp is a certification that evaluates and certifies businesses that balance purpose and profit. We started our application early 2019 with the assessment and evaluation process [...]
Jakarta Prisons Project
Indonesia has the third highest burden of tuberculosis in the world, following only after China and India. Even though Indonesia has made remarkable progress over the last decade, TB still remains one of the [...]
CAD4COVID Comparable in Performance to Radiologists
Nijmegen, 20th May 2020 – Research published in journal Radiology shows that artificial intelligence tool CAD4COVID can perform comparably to radiologists in triaging suspected COVID-19 cases by analysing chest X-rays. The software application was developed [...]
CAD4COVID will be installed in 55 hospitals in Ghana
With now more than 6,000 confirmed cases across all Ghana, it was essential that Ghana would take measures to fight and contain the COVID-19 virus. Together with the support of the Netherlands Enterprise Agency (RVO) [...]
Radio 1 News Interview
This morning at 6 AM, our CEO, Guido Geerts, was interviewed on the NOS Radio 1 news to talk about the launch of our free software CAD4COVID and how it's being used in the [...]
Follow us on Twitter